Synagistics Limited — Board/Management Information 2019

Apr 16, 2019

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [66 x 45] intentionally omitted <==

==> picture [34 x 40] intentionally omitted <==

OP FINANCIAL LIMITED 東英金融有限公司[*] (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1140)

APPOINTMENT OF EXECUTIVE DIRECTOR AND CHANGE OF CHIEF EXECUTIVE OFFICER

The board (the “ Board ”) of directors (the “ Directors ”) of OP Financial Limited (the “ Company ”) is pleased to announce the appointment of Dr. Liu Zhiwei as executive Director and the Chief Executive Officer (the “ CEO ”) of the Company with effect from 16 April 2019.

Mr. Zhang Gaobo has resigned as the CEO with effect from 16 April 2019, he will stay on to serve the Company as the Chairman of the Board and the Chairman of the Nomination Committee of the Board.

The biographical details of Dr. Liu Zhiwei are set out below:

Dr. Liu, aged 51, obtained a bachelor’s degree in Industrial Management Engineering from Zhe Jiang University in 1989. He furthered his studies in Graduate School of the People’s Bank of China between 1989 and 1992 and obtained his master’s degree in international finance. In 2007, he obtained a doctoral degree in Economics & Law from Hunan University. Dr. Liu completed a professional programme in Finance CEO from Cheung Kong Graduate School of Business in 2010.

Dr. Liu has over 20 years of experience in financing, securities investment and capital market. He is an entrepreneur and is currently the chairman of each of Shanghai Chunda Asset Management Co., Ltd and Bestone Asset Management Company Limited. Dr. Liu served as a non-executive director of the Company for the period from 1 December 2015 to 27 June 2016 and served as an executive director from 28 June 2016 to 28 June 2018. He served as a nonexecutive director of Shanghai Zendai Property Limited (stock code: 755), whose shares are listed on The Stock Exchange of Hong Kong Limited (“ Stock Exchange ”) for the period from 2 February 2010 to 12 December 2012. He was the vice-chairman of Chang’an International Trust Co., Ltd (formerly known as Xi’an International Trust Co., Ltd) from 2008 to 2011.

• For identification purpose only

– 1 –

Dr. Liu served as a supervisor of Xin Jiang Hui-tong (Group) Co., Ltd (stock code: 415) from December 2005 to December 2008, whose shares are listed on the Shenzhen Stock Exchange. He also served as a general manager of the merger and acquisition department of Guosen Securities Co., Ltd from 1997 to 1998.

Dr. Liu entered an appointment letter with the Company on 16 April 2019. His directorship with the Company is subject to retirement for re-election at the next general meeting of the Company in accordance with the articles of association of the Company, and should not be more than three years for each appointment. There is no specified term for the appointment of the CEO but each party to the appointment letter may terminate the appointment by giving the other party one month’s prior written notice.

Dr. Liu’s remuneration will be determined by the Board with reference to his experience, duties and responsibilities with the Company and prevailing market conditions of companies of comparable size and similar operations, and will be subject to review by the Remuneration Committee of the Company from time to time.

Save as disclosed above, Dr. Liu (i) does not have any relationship with any Director, senior management, substantial or controlling shareholder (having the meaning ascribed to it in the Rules Governing the Listing of Securities on the Stock Exchange (“ Listing Rules ”)) of the Company; and (ii) does not hold any other positions with the Company or its subsidiaries; and (iii) did not hold any directorship in the three years immediately preceding the date of this announcement in public companies, the securities of which are listed on any securities market in Hong Kong or overseas.

As at the date of this announcement, Dr. Liu has personal interests of 391,954,000 ordinary shares of the Company (representing approximately 13.34% of the entire issued share capital).

Other than the above, there are no other matters in relation to the appointment of Dr. Liu that need to be brought to the attention of the shareholders of the Company, nor is there any information that should be disclosed pursuant to any of the requirements of Chapter 13.51(2)(h) to 13.51(2)(v) of the Listing Rules.

The Board would like to take this opportunity to express its gratitude to Mr. Zhang Gaobo for his contribution to the Company during his tenure of office as the CEO since 2003, and welcome Dr. Liu for joining the Board.

By order of the Board OP Financial Limited Zhang Gaobo Executive Director and Chairman

Hong Kong, 16 April 2019

As at the date of this announcement, the Board comprises four executive Directors, namely, Mr. Zhang Zhi Ping, Mr. Zhang Gaobo, Dr. Liu Zhiwei and Mr. Zhang Weidong; three nonexecutive Directors, namely Dr. Wu Zhong, Mr. Chen Yuming and Dr. Fu Weigang; and three independent non-executive Directors, namely, Mr. Kwong Che Keung, Gordon, Professor He Jia and Mr. Wang Xiaojun.

– 2 –